CLOPIQ A 150

CLOPIQ A 150 contains Clopidogrel 75 mg + Aspirin 150 mg (enteric coated), a combination used to prevent blood clot formation in high-risk cardiac patients. Clopidogrel inhibits platelet aggregation, while aspirin enhances antiplatelet action. Together, they help maintain smooth blood flow and reduce the risk of heart attack and stroke. It is commonly prescribed after cardiac events or procedures for long-term cardiovascular protection.